Announcements Trials
Browse Landscape

Phase

Phase 1 50Phase 1/2 36Phase 2 22Phase EARLY_PHASE1 9Phase NA 6Phase 2/3 3Phase 3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, B-Cell 1Hematologic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Immunotherapy, Adoptive × Clear all
NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting
210 enrolled
Lymphoid

Lymphoma, B-Cell

NCT06238336 2024-02-02

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Shanxi Bethune Hospital

Phase 2/3 Unknown
30 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02851784 2021-03-04

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Chinese PLA General Hospital

Phase 2/3 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡